牙周治疗对糖尿病结局影响的潜在作用的证据更新。
An update of the evidence on the potential impact of periodontal therapy on diabetes outcomes.
机构信息
Department of Periodontology, School of Dentistry, National and Kapodistrian University of Athens, Athens, Greece.
出版信息
J Clin Periodontol. 2018 Feb;45(2):188-195. doi: 10.1111/jcpe.12836. Epub 2017 Dec 26.
AIM
To provide an update of the systematic review by Engebretson and Kocher J Clin Periodontol. 2013 Apr;40 Suppl 14:S153 on the effect of periodontal therapy on glycaemic control of people with diabetes.
METHODS
PubMed Literature search restricted to meta-analyses published from 2013 to the present was conducted. The search resulted in seven meta-analyses of RCTs.
RESULTS
Reduction in HbA1c at 3-4 months was reported in all reviews for the treatment group ranging from -0.27% (95% CI: -0.46, -0.07, p = .007) to -1.03% (95% CI: 0.36, -1.70, p = 0.003). At 6 months post-treatment, an HbA1c reduction ranging from -0.02 (95% CI: -0.20, -0.16, p = .84) to -1.18% (95% CI: 0.72%, 1.64%, p < 0.001) was reported.
CLINICAL RELEVANCE
The magnitude of the reduction in HbA1c, which is found to be associated with non-surgical periodontal treatment in patients with diabetes, seems to have clinically significant effects on systemic health, and thus should have a place in the treatment of diabetic patients.
CONCLUSIONS
Periodontal treatment (SRP) results in a statistically significant reduction in HbA1C levels at 3 months, with a lower reduction at 6 months.
目的
对 Engebretson 和 Kocher 发表于 2013 年 4 月《临床牙周病学杂志》40 增刊 14 期的综述进行更新,该综述评估了牙周治疗对糖尿病患者血糖控制的影响。
方法
对 2013 年至今发表的荟萃分析进行了 PubMed 文献检索,共检索到 7 篇 RCT 的荟萃分析。
结果
所有综述均报道了治疗组在 3-4 个月时 HbA1c 的降低,范围为-0.27%(95% CI:-0.46,-0.07,p = 0.007)至-1.03%(95% CI:0.36,-1.70,p = 0.003)。在治疗后 6 个月时,HbA1c 的降低范围为-0.02(95% CI:-0.20,-0.16,p = 0.84)至-1.18%(95% CI:0.72%,1.64%,p < 0.001)。
临床相关性
在糖尿病患者中,非手术牙周治疗与 HbA1c 降低的幅度相关,这种降低幅度似乎对全身健康具有显著的临床意义,因此应该在糖尿病患者的治疗中占有一席之地。
结论
牙周治疗(SRP)可使 HbA1C 水平在 3 个月时显著降低,6 个月时降低幅度较低。